J.Safra Asset Management »

Janux Therapeutics shares owned by J.Safra Asset Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by J.Safra Asset Management from 13F filings

Historical chart of J.Safra Asset Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by J.Safra Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by J.Safra Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.1k 86 24.44
2025-06-30 $2.0k 86 23.10
2025-03-31 $1.8k 66 27.00
2024-12-31 $525 10 52.50
2024-09-30 $323 7 46.29

More positions owned by J.Safra Asset Management

Invesco Qqq Tr Unit Ser 1 Unit Ser 1 (QQQ)
Select Sector Spdr Trust The Technology Select Sector Spdr Fund Technology (XLK)
Ishares Russell 1000 Growth Etf Rus 1000 Grw Etf (IWF)
Select Sector Spdr Trust The Communication Services Select Sector Spdr Fund Communication (XLC)
Listed Funds Trust Roundhill Magnificent Seven Etf Roundhill Magnif (MAGS)
Select Sector Spdr Trust The Financial Select Sector Spdr Fund Financial (XLF)
Ishares Msci All Country Asia Ex Japan Index Fund Msci Ac Asia Etf (AAXJ)
Vanguard Intl Equity Ind Fd Ftse All World Ex Us Fd Etf Allwrld Ex Us (VEU)
Select Sector Spdr Trust The Energy Select Sector Spdr Fund Energy (XLE)
Select Sector Spdr Trust The Health Care Select Sector Spdr Fund Sbi Healthcare (XLV)
Spdr S&p Dividend Etf S&P Divid EFT (SDY)
Select Sector Spdr Trust The Industrial Select Sector Spdr Fund Indl (XLI)
Spdr S&p 500 Etf Trust Etf Tr Unit (SPY)
Spdr Ser Tr S&p Ins Etf S&p Ins Etf (KIE)
Vaneck Etf Tr Vaneck Semiconductor Etf Semiconductr Etf (SMH)

View all positions for J.Safra Asset Management

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Logos Global Management
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Readystate Asset Management

View all funds holding Janux Therapeutics